Introduction: When chondrocytes loose their cartilagenous phenotype (dedifferentiation), they produce extra-cellular matrix of inferior quality, accompanied by a shift from collagen type II and aggrecan production to collagen type I and versican synthesis [1]. A loss of the chondrogenic phenotype is observed after in vitro monolayer expansion of isolated chondrocytes, as required for several cell-based therapies, and may also play a role in the pathogenesis of osteoarthritis [2].
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From the different signaling pathways that have been implicated in regulating chondrogenic differentiation and dedifferentiation, we focused on the calcineurin (Cn) -nuclear factor of activated T cells (NFAT) route. Results from various studies suggest a role for the Cn-NFAT route, however, the results are not pointing in one direction. The Cn inhibitor FK506 (Tacrolimus) is described to induce chondrogenesis in clonal mouse embryogenic carcinoma cells [3] and in human synovial stromal cells [4] . However, Cn and its substrate NFATc3 are reported to induce chondrogenesis in limb bud mesemchyme [5] , whereas murine NFATc2 (NFATp) likely acts as a repressor of cartilage formation, since NFATc2 knock-out mice showed extra-articular cartilage formation [6] .
Although these data suggest that the Cn-NFAT route plays an important role in embryonic chondrogenesis, and a recent report suggests the involvement of Cn in the progression of osteoarthritis [7] , still virtually nothing is known about Cn and NFATs in the phenotypical regulation of adult human articular chondrocytes.
The aim of this study was to evaluate the Cn-NFAT pathway in regulating adult human articular chondrocyte differentiation, and to study the effects of blocking this pathway with FK506, using in-vitro experiments.
Materials and Methods: Articular chondrocytes were harvested from full thickness cartilage of 6 patients undergoing total knee replacement surgery. Isolated cells were cultured in monolayers (7500/cm2) for 3 passages (dedifferentiation). Immediately after harvesting from the cartilage (P0) and after 1, 2 and 3 passages, cells were cultured in high density (20k/cm2) for 4 days before harvesting for Cn-NFAT analyses. P2 cells were also 3D-cultured in alginate beads in redifferentiation medium (DMEM,10% FCS, 1:100 ITSI, 10 ng/mL TGFβ2) for 21 days (redifferentiation).
To study the regulation of the Cn-NFAT pathway, calcineurin activity was measured on cytoplasmatic extracts, using a Calcineurin Cellular Assay Kit Plus (Tebu-Bio, NL) and gene expression of NFATc1-c4 and of the catalytic Cn subunit (CnA) isoforms α, β and γ was measured. Gene expression of collagen type II (COL2) and type I (COL1), SOX9 and aggrecan (AGC1) was studied as chondrogenic markers, and that of collagen type X (COL10) and matrix metalloproteinase 13 (MMP 13) as indicators of chondrocyte hypertrophy. GAPDH-normalized relative gene expression was measured according to the 2-ΔCt method [8] by QPCR.
In addition, the short-and long-term effects of the Cn inhibitor FK506 (500 ng/mL) on chondrocyte phenotype were determined (respectively after 4 hours and 10 days of addition).
Results: Cn activity increased during chondrocyte dedifferentiation, up to 2-fold in P3 cells, and decreased by a factor 20 after redifferentiation. NFATc4 gene expression also increased during dedifferentiation and decreased during redifferentiation, whereas NFATc2 showed the opposite trend, similar to that of COL2 (Figure 1, n=6) . The expression of NFATc1, NFATc3 and all CnA isoforms was not significantly regulated during chondrocyte differentiation (data not shown). Addition of 500 ng/mL FK506 for 4 hours and 10 days decreased Cn activity and resulted in a more chondrogenic phenotype, with increased COL2 (Figure 2, n=9) and decreased MMP13 expression (data not shown), while expression of NFATc2 was increased by FK506 and that of NFATc4 decreased (Figure 2, n=9 ). Discussion: These results suggest a regulating role for Cn-NFAT signaling in chondrogenic differentiation of articular chondrocytes in vitro. Blocking this pathway with the calcineurin inhibitor FK506 increases the expression of chondrogenic markers, supporting an improved chondrogenic phenotype of chondrocytes in vitro. Therefore, FK506 might be useful for cartilage tissue engineering purposes and other cell-based therapies, or for in-vivo application to enhance the repair of focal chondral lesions. Our results might also explain how calcineurin is involved in the progression of osteoarthritis [7] , as it may drive chondrocyte dedifferentiation.
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